|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Regulatory Affairs 101!
“Check out AAPS’ newest eCourse, Regulatory Affairs 101! This innovative lecture series is a convenient, self-paced learning tool that provides an overview as well as cross-functional training in regulatory sciences to better understand current regulatory processes from discovery to commercialization of pharmaceutical products. Available Today!”
What to Expect in Your Next Offer Letter
Searching for a new job can be an exhausting process, and oftentimes the only light at the end of the tunnel is being able to land an offer at the end. While you may be inclined to sign on the dotted line right away — and the employer is likely pushing you to do so — it is important to take a step back and review the offer as a whole before committing. As the industry has evolved, so have the compensation packages. Here is what is trending in the HR world and what to look for in your next offer letter.
Base pay is the first aspect of a job offer that you’re drawn to, and when your receive it, that number should make you excited. Unless internal equity prevents an increase, hiring managers strive to beat a candidate’s current base by at least 5 percent.
Read more in the July 2014 issue of the AAPS Newsmagazine (member login required).
To become an AAPS Member, contact us today!
The first AAPS Virtual Career Fair a big success!
We want to thank the hundreds of participants and the participating employers (ABC Laboratories, Actavis Inc, Celgene, GlaxoSmithKline, & Regeneron Pharmaceuticals) for making our first AAPS virtual career fair a success. Keep an eye out for our next virtual career fair coming soon!
PHARMACEUTICAL CAREER NEWS
Novartis To Build $35 Million Data Center At Alcon Campus
Fort Worth Star-Telegram
Novartis, which owns Alcon Laboratories, will begin construction soon on a $35 million global data center at Alcon’s campus in south Fort Worth that will serve the Swiss pharmaceutical giant’s operations in North America and South America.
The project is the latest investment in Fort Worth since Novartis acquired Alcon, a producer of eye-care surgical products and pharmaceuticals, in 2011. Fort Worth was chosen as the site for the data center last year after Novartis conducted a study to compare potential locations, said Elizabeth Harness Murphy, an Alcon spokeswoman.
5 Reasons Why Diversity Is Crucial For Success
By Scott Steinberg
As you may have noticed, most working professionals tend to surround themselves with like-minded individuals who have similar backgrounds, experiences and education. We naturally want to be liked, and liked by our people in turn: Only through the support of our colleagues and teamwork can we be most effective.
99 Percent of Alzheimer's Drug Trials Fail, Study Says
Drug Discovery & Development
Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer’s disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments. The paper, “Alzheimer's Disease Drug Development Pipeline: Few Candidates, Frequent Failures,” is published in the journal Alzheimer's Research & Therapy.
How To Spot A Fake Job Ad
My Small Business
The hundreds of new job ads posted online daily is for pundits the sign of a thriving jobs market – but how many of them are real?
Reports from disgruntled job seekers tell a different story – that many job ads are merely "fishing expeditions" by recruitment agencies wanting to pad out their databases.
HD Biosciences And MIIR Partner To Co-Develop Potential Anti-Cancer Drugs
Under the agreement, the partners will share the costs and risks of discovery and development of new drugs. They will also jointly own intellectual property and commercialization rights of the products developed through the collaboration. HDB will take lead compounds that have been discovered in Marshall University to continue the preclinical development, while the university is well versed in translational medicine, clinical trials and the U.S. Food and Drug Administration guidelines. This partnership is committed to providing innovative medicines for unmet healthcare needs, and targets on both international and Chinese markets.
Follow These 8 Tips When Writing Your Resume
By Jessica Taylor
Seeking employment can become a full-time job in itself. And with any job, you will always make mistakes and get frustrated. Let's face it, we can't all be perfect because we're only human.
After graduation, I found myself searching for jobs after my regular full-time job. As soon as I would send my resume and cover letter over to an employer, I would find a mistake — even after going over the entire thing multiple times.
Hospira Acquires Orchid's API Manufacturing and R&D Facilities
Pharmaceutical Technology Magazine
Hospira reported it has completed the acquisition of an API manufacturing facility and an associated R&D facility from Orchid Chemicals & Pharmaceuticals, an Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.
The acquisition enables Hospira to vertically integrate into the beta-lactam antibiotic APIs (penems and penicillins) and is also expected to improve Hospira's cost position in this therapeutic space.
Actavis Earth City Lab Closing Affects 190 Employees
The pharmaceutical company Actavis has announced today that it will be closing its Forest Laboratories in Earth City, Missouri. Actavis acquired Forest Laboratories in February, and has found that production at some of their facilities can be combined.
Following this decision, there will be immediate transitions taking place at Actavis. The warehousing and distribution related activities at Earth City will be moved to another Actavis facility in Gurnee, Illinois. Actavis reports that over time there will be more transitions from Earth City to other Actavis sites.
Dezima Extends Clinical Development of Dyslipidemia Drug
Drug Discovery & Development
Dezima Pharma, the biotechnology company developing innovative drugs in the field of dyslipidemia, announced the approval of a Phase 1 pilot study in subjects with isolated, elevated Lipoprotein(a) (Lp(a)), for which additional funding has been secured.
The aim of this new study is to investigate the Lp(a) lowering effects of TA-8995 (DEZ-001), a best-in-class CETP inhibitor, in 36 asymptomatic subjects with isolated, elevated Lp(a) levels.
Bringing World Cup Passion To Your Office
By Jessica Taylor
Being a leader in any job can be difficult, but with the right attitude you can affect multiple people around you. I've learned through all of my job experiences that employees reflect their leaders. And "attitude reflects leadership" — to quote my favorite movie, "Remember the Titans."
So as I’m gearing up to cheer on Team USA in the next round, I've been thinking that I need to be as devoted to my company as fans are to their sports teams.
With that said, here's why leaders are just like a sports team and your employees are your fans.
AstraZeneca Spreads Its Virtual Reach To Cardio R&D With New Partnership
AstraZeneca is expanding iMed, its virtual R&D project, through a cardiovascular-focused agreement with Germany's Max Planck Institute of Molecular Physiology that will focus on early-stage research.
Under the agreement, scientists at AstraZeneca's iMed satellite outpost in Mölndal, Sweden, will work alongside Max Planck researchers to study new modalities in chemistry such as stabilized peptides, macrocycles and conjugation chemistry, the partners said.
Supreme Court Supports Religious Freedom Of Businesses
By Jessica Taylor
A potentially landmark decision on religious liberty occurred June 30 in the U.S. Supreme Court — and religious freedom won.
The court ruled in favor of business owners objecting on religious grounds to a provision of the Affordable Care Act. Two companies — Hobby Lobby and Conestoga Wood Specialties — came together to sue the Obama administration because the Affordable Care Act requires each company to provide health insurance that includes contraception.
AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit
Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
June 13, 2014
May 9, 2014
April 11, 2014
March 14, 2014
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063